| Financial Year |
March 31 2023 |
| Monetary Funds |
645,152,310.62 |
| Held-for-trading Financial Assets |
944,555,230.63 |
| Notes Receivable |
85,689,387.41 |
| Accounts Receivable |
391,683,081.34 |
| Advances to Suppliers |
32,931,696.77 |
| Other Receivables |
7,855,215.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
462,600,458.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
52,910,485.58 |
| Total Current Assets |
2,665,509,128.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
154,464.45 |
| Long-term Equity Investment |
10,008,589.44 |
| Investment Properties |
-- |
| Fixed Assetes |
1,599,605,298.99 |
| Under-construction Projects |
288,179,136.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
415,154,202.40 |
| R&D expenses |
11,515,743.91 |
| Goodwill |
85,164,268.03 |
| Long-Term Deferred and Prepaid Expenses |
6,539,524.61 |
| Deferred Income Tax Assets |
75,503,138.08 |
| Other Non-Current Assets |
29,951,460.32 |
| Sub-Total of Non-Current Assets |
2,605,850,326.63 |
| Total Assets |
5,271,359,455.52 |
| Short-Term Loans |
70,056,221.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
65,785,129.08 |
| Accounts Payable |
237,359,355.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
96,671,155.44 |
| Taxes Payable |
26,866,765.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
23,300,601.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
78,011,594.23 |
| Other Current Liabilities |
30,913,385.36 |
| Sub-Total of Current Liabilities |
637,947,834.56 |
| Long-term Loans |
280,500,000.00 |
| Bonds Payable |
878,815,121.08 |
| Long-Term Accounts Payable |
201,702,709.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,346,006.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,898,023,310.38 |
| Total Liabilities |
2,535,971,144.94 |
| Paid-In Capital(Or Share Stock) |
543,702,550.00 |
| Capital Surplus |
750,802,919.43 |
| Surplus Reserve |
66,999,815.28 |
| LESS:Treasury Stock |
15,406,704.00 |
| Undistributed Profits |
835,192,154.46 |
| Minority Stockholder's Interest |
536,758,182.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,198,630,128.37 |
| Owner's Equity（Stockholder's Equity） |
2,735,388,310.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,271,359,455.52 |
